- Research article
- Open Access
Leaving no one behind? An equity analysis of the HIV care cascade among a cohort of people living with HIV in Manitoba, Canada
BMC Public Health volume 21, Article number: 281 (2021)
Manitoba is a central Canadian province with annual rates of new HIV infections consistently higher than the Canadian average. National surveillance statistics and data from the provincial HIV care program suggest that epidemiological heterogeneity exists across Manitoba. New HIV cases are disproportionately reported among females, Indigenous-identifying individuals, and those with a history of injection drug use. Given the heterogeneity in acquisition, it is of interest to understand whether this translates into inequalities in HIV care across Manitoba.
A sample of 703 participants from a clinical cohort of people living with HIV in Manitoba, with data current to the end of 2017, was used to conduct cross-sectional, disaggregated analyses of the HIV care cascade to identify heterogeneity in service coverage and clinical outcomes among different groups receiving HIV care in Manitoba. Equiplots are used to identify and visualize inequalities across the cascade. Exploratory multivariable logistic regression models quantify associations between equity variables (age, sex, geography, ethnicity, immigration status, exposure category) and progression along the cascade. Adjusted odds ratios (AOR) and 95% confidence intervals (95%CI) are reported.
Equity analyses highlight inequalities in engagement in and coverage of HIV-related health services among cohort participants. Equiplots illustrate that the proportion of participants in each cascade step is greater for those who are older, white, non-immigrants, and report no history of injection drug use. Compared to those living in Winnipeg, participants in eastern Manitoba have greater odds of achieving virologic suppression (AOR[95%CI] = 3.8[1.3–11.2]). The odds of Indigenous participants being virologically suppressed is half that of white participants (AOR[95%CI] = 0.5[0.3–0.7]), whereas African/Caribbean/Black participants are significantly less likely than white participants to be in care and retained in care (AOR[95%CI] = 0.3[0.2–0.7] and 0.4[0.2–0.9], respectively).
Inequalities exist across the cascade for different groups of Manitobans living with HIV; equiplots are an innovative method for visualizing these inequalities. Alongside future research aiming to understand why inequalities exist across the cascade in Manitoba, our equity analyses can generate hypotheses and provide evidence to inform patient-centred care plans that meet the needs of diverse client subgroups and advocate for policy changes that facilitate more equitable HIV care across the province.
Manitoba is a central Canadian province where annual rates of new HIV infections are consistently higher than the national average (7.9 vs. 6.9 per 100,000 population, respectively, in 2018) . Injection drug use (33.9%), condomless anal sex between men (24.4%), and condomless vaginal (heterosexual) sex (20.9%) are the most commonly identified HIV risk exposures in Manitoba , and new infections in 2018 were disproportionately high, compared to the rest of Canada, among individuals identifying as Indigenous (50% vs. 19.3%) and female (40% vs. 29.3%) [1, 3]. Additionally, notable heterogeneity in rates of new HIV infection exists across the province by geography, age, and sex —in 2018, 77.6% of new diagnoses occurred in Winnipeg, the provincial capital and main urban centre, and among newly diagnosed females, 11.6% were ≤ 19 years (compared to 1.6% of males) and 14.0% were ≥ 60 years (compared to 3.1% of males) . At the end of 2018, Manitoba Health, Seniors and Active Living (MSHAL), estimated that 1572 people were living with HIV in the province (personal communication, J. Paul, April 16, 2020), and the Manitoba HIV Program—the primary provider of HIV care in the province—estimated that approximately 1400 people were in care in the same year .
Over the past decade of HIV research, heavy emphasis has been placed on the HIV care cascade (“the cascade”)—a framework and analytic tool providing insights into the continuum of care services for people living with HIV [4,5,6]—and its simplified counterparts the 90–90-90 Initiative . Conventionally, cascades use aggregate data to illustrate the proportion of individuals in a population of people living with HIV who have been diagnosed, linked to HIV care services, retained in care, then initiated and sustained on HIV treatment to, ultimately, reach virologic suppression. Using aggregate data to illustrate the continuum of HIV care for an entire population is useful insofar as it can provide a general picture of points of “leakage” or “bottlenecks” within a health system or care program. However, relying on aggregate data to paint a picture of an entire population risks obscuring the underlying heterogeneity among and between individuals and groups who make up the population. To generate evidence that can help to inform the development and optimization of interventions and programs addressing inequities in HIV care, it is crucial to conduct equity analyses that generate disaggregated cascades to showcase nuances and highlight inequalities across the cascade steps within a population.
In 2015, all 193 Member States of the United Nations agreed upon the 2030 Agenda for Sustainable Development, comprising seventeen Sustainable Development Goals (SDGs), which built upon the Millennium Development Goals (MDGs) introduced fifteen years earlier . At the core of the SDGs is the notion of leaving no one behind, which, “represents the unequivocal commitment … to reduce the inequalities and vulnerabilities that leave people behind and undermine the potential of individuals and of humanity as a whole” [9 , p. 6]. This idea underscores the interconnectedness of the SDGs and principles of health equity —a noted limitation of the MDGs . As such, under the auspices of the SDGs , there is a need for research that focuses on identifying (health) inequalities that exist, examining the factors that perpetuate and exacerbate these inequalities, understanding how specific inequalities are related to broader health inequity , and developing strategies to minimize or, ideally, eliminate them. As noted in SDG 17, to adequately assess (in)equities, it is necessary that data are disaggregated by socioeconomic, demographic and other relevant, context-specific characteristics [11, 12].
Publicly available HIV epidemiological data in Manitoba are limited to reports published by the Public Health Agency of Canada (PHAC)  and MHSAL , which focus solely on surveillance data. As such, local understandings of inequalities in HIV care and clinical outcomes among different groups in the province are rudimentary. In 2013—through the support of a multi-site program of research, Advancing Primary Healthcare for Persons Living with HIV in Canada (the LHIV Study), funded by the Canadian Institutes of Health Research —a prospective clinical cohort of people living with HIV and/or receiving HIV care in Manitoba was established as an embedded research project within the Manitoba HIV Program . The establishment of the LHIV-Manitoba cohort opens up numerous analytic opportunities to better understand HIV epidemiology in Manitoba and, for the first time, provides access to de-identified, individual-level clinical data, allowing for disaggregated analyses to take place.
Here, building upon previous work [15,16,17], we use equiplots to present disaggregated cascade analyses (by age, sex, geography, ethnicity, immigration status, and HIV exposure category) that visualize inequalities in service uptake and clinical outcomes among LHIV-Manitoba cohort participants who were alive as of 31 December 2017 and had received an HIV diagnosis on or before that date. Exploratory multivariable logistic regression analyses are used to quantify these inequalities, generate hypotheses, and provide guidance for future cascade research in Manitoba. In conjunction with future research to understand why identified inequalities exist across the cascade  and how these inequalities contribute to health inequities , our examination of the cascade through an equity lens [18, 19] will provide Manitoba’s provincial care program with evidence needed to develop patient-centred care plans that meet the needs of heterogeneous client subgroups, and to advocate for policy changes addressing inequities in HIV care across the province.
Manitoba has a population of 1.36-million people, spanning over 550,000 km2. Approximately 57% of Manitoba’s population lives in the capital city of Winnipeg, 37% in the western, eastern, and southern regions (rural), and 6% in the north (rural-remote) . HIV care in Manitoba is primarily provided through the Manitoba HIV Program, comprising three clinics—two in Winnipeg and one in a smaller, rural city in southwestern Manitoba. As such, the majority of Program clients living in rural and rural-remote regions of the province are required to travel substantial distances to attend clinic appointments. The Manitoba HIV Program employs a multidisciplinary care model encompassing a full complement of health and social service providers, including HIV specialists and family physicians, nurses, pharmacists, social workers, and other allied health professionals. Despite Canada’s publicly funded healthcare system, no Canadian provinces or territories have a single drug plan that provides universal coverage for all, and out-of-pocket expenses associated with prescription medications vary substantially depending on an individual’s insurance coverage .
Data used to generate disaggregated, cross-sectional analyses of the Manitoban cascade are derived from the LHIV-Manitoba clinical cohort dataset, comprising individual-level, de-identified clinical data linked to provincial administrative health databases. Clinical cohort data are linked to the most recently available administrative health datasets and are reported up to 31 December 2017. Manitoba’s administrative datasets include individual-level records for nearly all contacts within the province’s healthcare system. Linked administrative data within the cohort include variables pertaining to physician visits, hospital admissions, prescription drug dispensation, and laboratory testing, including quantitative HIV plasma viral load data . The process of establishing the cohort, a complete profile of cohort participants, and a comprehensive description of the datasets is detailed in earlier work . Briefly, the cohort includes 890 unique individuals, comprising 63.6% of the estimated 1400 clients receiving care from the Manitoba HIV Program and 56.6% of the estimated 1572 people living with diagnosed HIV in the province. All adults (≥18 years) living with HIV and/or receiving HIV care in Manitoba were eligible for participation, unless under the jurisdiction of the Public Guardian and Trustee of Manitoba or otherwise unable to make their own healthcare decisions. Potential participants have the opportunity to agree to any combination of three separate components of the LHIV-Manitoba cohort study: (i) have their clinical data collected; (ii) have their clinical data linked to provincial administrative health datasets; and/or (iii) indicate interest in being approached about participating in future HIV research studies . In total, 725 (81.5%) cohort participants agreed to have their data extracted from clinical records, and 703 (78.9%) of those participants also agreed to have their clinical data anonymously linked to administrative health databases. A limited clinical dataset exists for an additional 165 individuals whose clinical records were reviewed posthumously and linked to administrative health databases. In total, the linked dataset comprises 868 participants. Missing data were minimal throughout the cohort dataset—9.1% (n = 81) of all participants who were alive at enrolment are missing observations from at least one key variable of interest . Missing data points are excluded from relevant analyses. All cohort participants who were alive as of 31 December 2017, had received a positive HIV diagnosis at any point on or before the same date, and had provided written, informed consent to have their clinical data reviewed and linked to administrative health datasets were included in a baseline HIV care cascade model and subsequent equity analyses.
An HIV care cascade has previously been developed and specifically tailored to accommodate available data sources within Manitoba . The existence of a single insurer responsible for payment of the majority of health services in the province (MHSAL) and linkable, population-based administrative health databases afforded opportunities for developing sensitive and data-intensive indicator definitions [16, 17] similar to definitions used in other provinces [22, 23]. Table 1 outlines the established definitions for five indicators representing each step of the Manitoban cascade, which were derived data from both clinical cohort data (CD4 cell count data) and linked administrative health datasets (viral load, physician visits, and drug dispensation data).
Throughout the paper, the term “inequality” describes measured differences in outcomes between groups, whereas “inequities” refer to the implications of population-level inequalities, which, in the context of public health, are understood to be fundamentally unjust or unfair . To examine inequalities across the Manitoban care cascade, we identified relevant equity variables available within the cohort by which each cascade step indicator was then disaggregated. These variables—which have been recommended for use in equity analyses previously [10, 11, 19]—included age; sex; geographic location of residence; self-identified ethnicity; immigration status; and primary HIV exposure category, identified using a “risk hierarchy” framework . A participant’s geography is categorized by provincial Regional Health Authority (Supplementary Figure, see Additional File 1), which is inferred from the postal code of residence recorded in the cohort database . Participants are categorized as “immigrants” if they were foreign-born and had immigrated to Canada in 2001 or later  (Maritim C, McClarty L, Leung S, Bruce S, Restall G, Migliardi P, Becker M. HIV treatment outcomes among newcomers living with HIV in Manitoba, Canada JAMMI In press), or “non-immigrants” if they were either Canadian-born or foreign-born, having immigrated to Canada before 2001.
To aid in the visualization of equity analyses, equiplots  were used to present the proportion of participants within each group—defined by key equity variables—who reach each cascade step, thus illustrating inequalities in progression along the cascade. Data were excluded from equiplot analyses for participants living outside of Manitoba or without a known permanent address. Equiplots were generated in Stata 15.1 (College Station, TX) using code available through the International Centre for Equity in Health, Universidad Federal de Pelotas, Brazil .
Multivariable logistic regression models
The in care, retained in care, on treatment, and virologically suppressed cascade steps (as defined in Table 1) were used as dichotomous outcome variables and the aforementioned equity variables were included as categorical exposure variables in multivariable logistic regression models. For each of the four outcomes of interest, six individual models were constructed to quantify associations between individual equity variables and reaching each cascade step. All equity variables were converted into dummy variables in the models and were tested for collinearity prior to inclusion. Cohort participants living outside of Manitoba and those who had no known address recorded in their medical files were excluded from multivariable models quantifying inequalities across the cascade, disaggregated by geographic region (Model 3 in Table 4). Adjusted odds ratios (AOR) are presented using 95% confidence intervals (95%CI) to assess statistical significance. Crude analyses from unadjusted models are presented in the Supplementary Table (see Additional File 2). All statistical analyses were performed using Stata 15.1 (College Station, TX).
In total, 703 cohort participants were alive and had received an HIV diagnosis as of 31 December 2017. Distributions of key equity variables among these participants, disaggregated by cascade step, are presented in Table 2.
Among the 703 alive and diagnosed participants (100%), 638 (90.8%) met the definition of in care, 606 (86.2%) were retained in care, 573 (81.5%) were on treatment, and 523 (74.4%) had reached the virologically suppressed step of the cascade at the end of the 2017 calendar year (Fig. 1).
Examining the cascade through an equity lens
Analyzing the Manitoba cascade data through an equity lens highlights a number of inequalities in the proportion of cohort participants who reached the in care, retained in care, on treatment, and virologically suppressed steps. Data corresponding to each of the presented equiplots are presented in Table 3.
Disaggregated by age group, cascade data (Fig. 2 and Table 3) indicate that a greater proportion of participants reach all four cascade steps with each increase in age group; multivariable logistic regression analyses (Model 1 in Table 4) support this visual interpretation. Compared to participants aged 18–29 years, those in the 40–49, 50–59, and 60–69 year age groups have significantly greater odds of being in care (AOR[95%CI] = 2.51[1.03–6.11], 4.53[1.73–11.89], 5.05[1.52–16.69], respectively), retained in care (AOR[95%CI] = 3.28[1.51–7.13], 3.69[1.67–8.14], and 6.37[2.27–17.85], respectively), on treatment (AOR[95%CI] = 2.01[0.96–4.24], 3.27[1.58–6.77], 4.39[2.08–9.30], 4.99[2.05–12.15], respectively), and virologically suppressed (AOR[95%CI] = 2.77[1.37–5.59], 3.75[1.83–7.68], 4.53[1.96–10.44], respectively). However, participants aged 30–39 years are only at significantly greater odds of being retained in care compared to the 18–29 year reference age group (AOR = 2.39, 95%CI:1.07–5.34).
The equiplot illustrating disaggregated cascade estimates for male and female participants (Fig. 3) highlights similarities between groups at each step with distinguishable, though small, differences in the in care (91.3 and 89.3%, respectively) and virologically suppressed (75.0 and 73.0%, respectively) cascade steps (Table 3). Data presented in Table 4 (Model 2) indicates that female participants tend to have greater odds of being in each successive cascade step compared to male participants, but these differences are not statistically significant.
Inequalities are observed between the proportions of cohort participants in each cascade step when data are disaggregated by geographic region (Fig. 4). Given that the majority (81.9%) of cohort participants reside in the Winnipeg, the proportion of Winnipeg-based cohort participants in each cascade step are similar to the cascade estimates for the entire cohort, depicted in Fig. 1. Visual analysis of equiplot data suggests very little leakage occurs between cascade steps among participants living in eastern Manitoba. However, Fig. 4 and Table 3 highlight substantial drop-off between the alive and diagnosed and in care steps among western Manitobans (100 to 76.0%), and between the on treatment and virologically suppressed steps among those living in northern (84.0 to 72.0%) and southern regions (77.8 to 55.6%). Logistic regression Model 3 (see Table 4) indicates that compared to those living in Winnipeg, the odds of being in care are significantly lower for participants living in western Manitoba (AOR = 0.33, 95%CI:0.12–0.90). Furthermore, compared to participants living in Winnipeg, the odds of being virologically suppressed for those living in eastern Manitoba is nearly four-times greater (AOR = 3.82, 95%CI:1.31–11.17).
Compared to all other ethnicity categories white cohort participants comprise the greatest proportion in each step across the cascade (Fig. 5). The proportions of participants identifying as sub-Saharan African/Caribbean/black (ACB) and those in the Other ethnicity category are relatively low in the in care step (83.5 and 83.3%, respectively), whereas the proportions of Indigenous participants in the on treatment and virologically suppressed steps are relatively low (77.0 and 65.1%, respectively). Accordingly, Model 4 in Table 4 highlights that compared to white participants, the adjusted odds of being in care is significantly lower for ACB participants (AOR = 0.34, 95%CI:0.15–0.73) and being categorized as retained in care is less likely for both ACB (AOR = 0.43, 95%CI:0.22–0.86) and Indigenous (AOR = 0.57, 95%CI:0.33–0.97) participants. Furthermore, the odds of being on treatment and reaching the virologically suppressed step are approximately half for Indigenous participants compared to white participants (AOR = 0.55, 95%CI:0.33–0.92 and AOR = 0.54, 95%CI:0.34–0.84, respectively).
After controlling for age group, sex, and ethnicity, a participant’s immigration status was not found to significantly influence their odds of being in a given cascade step (see Table 4, Model 5). However, the equiplot in Fig. 6 and data in Table 3 highlight a number of important inequalities between groups. In general, the proportion of participants who had immigrated to Canada in 2001 or later is notably lower than the proportion of non-immigrant participants in the in care (81.1% vs 92.2%, respectively), retained in care (77.8% vs 87.4%, respectively), and on treatment (75.6% vs 82.4%) cascade steps.
HIV exposure category
Disaggregating cascade data by HIV exposure category (Fig. 7) revealed few inequalities across cascade steps. Most notably, the proportion of participants whose primary HIV risk is injection drug use (IDU) categorized as virologically suppressed (61.8%) is at least 15% lower than the same for all other groups (Table 3). Compared to male participants reporting condomless anal sex with other men (MSM), participants with a history of IDU are half as likely to be included in the virologically suppressed step (Model 6 in Table 4, AOR = 0.48, 95%CI:0.27–0.85). The proportion of participants reporting condomless sex—either anal or vaginal—as their primary HIV exposure categories are distributed similarly across cascade steps (Fig. 7), although a slight inequality emerges between these groups at the virologically suppressed step (78.6% vs 74.8%, respectively).
In general, our data indicate that Manitobans living with HIV are progressing well along the cascade and are nearly meeting 90–90-90 targets—81.5% of those alive and diagnosed are on treatment and 91.3% of those on treatment are virologically suppressed (Fig. 1). However, equity analyses highlight important inequalities in progression along the HIV care cascade among cohort participants within different sociodemographic groups. Disaggregating our cascade data calls attention to clear inequalities in HIV care and outcomes by age, geography, and ethnicity among cohort participants. In general, individuals who are younger and non-white are less likely than their counterparts to reach subsequent cascade steps. Notable heterogeneity also exists along the cascade based on participants’ reported HIV exposure categories, with MSM progressing relatively well participants reporting IDU having relatively poor odds of reaching virologic suppression. These trends are not unprecedented; similar inequalities across the cascade have been noted in a variety of contexts [28,30,31,32,32]. While our multivariable logistic regression analyses highlight specific inequalities of statistical significance across the cascade, the use of equiplots to analyze disaggregated cascade data is an innovative and important method for identifying inequalities that, although not statistically significant, are highly relevant and should be considered during programmatic planning and design to address population-level inequities in HIV-related health outcomes. On the quest to generate evidence that can inform policy and program development aimed at minimizing health inequities, using cascade data, both aggregated and disaggregated, to identify inequalities in health outcomes and service access, delivery, and utilization is necessary, but insufficient. As Seckinelgin  and Zamora and colleagues  have argued, employing additional methodologies, such as qualitative inquiry and community-based participatory research, to inform policy and program design is crucial.
When it was first introduced in 2011 by Gardner and colleagues , the spectrum of engagement of HIV care, which ultimately became the HIV care cascade, was framed as an analytic tool for mapping individual- and population-level progression through the continuum of HIV care services. Specifically, Gardner’s model  provides a framework through which to determine the proportion of individuals in various stages along the continuum, and to “explore the potential impact of interventions to improve engagement in care” (p.795). However, over time, the cascade, and its simplified counterparts, the 90–90-90 Initiative  and the 95–95-95 Fast-Track targets , have been adopted or endorsed by global technical and policy normative bodies (e.g. UNAIDS [7, 33] and the World Health Organization ), and used to guide and influence international HIV policy development . Expanding the utility of the cascade framework from an analytic tool to a large-scale decision- and policy-making framework is problematic because, as Seckinelgin  notes, “the model itself does not analyse the broader socio-political and economic conditions that interact with individuals’ experiences of HIV and that inform their decisions to engage with health services” . In the process of developing health policies that align with the principles of health equity and the SDG commitment to leaving no one behind, it is essential for decision-makers to thoroughly consider how social determinants of health influence and manifest inequalities in health outcomes and access to health services [10, 35].
As we demonstrated, performing equity analyses using HIV care cascade data, and illustrating inequalities along the cascade using equiplots, concisely draws attention to points along the cascade at which specific groups of individuals are unable to optimally engage in HIV care or reach target health outcomes. Still, these analyses provide insufficient context or explanation for leakages along the cascade. In order to appreciate nuances in observed inequalities across the cascade, and to understand, for example, why people are having a hard time engaging in their HIV care and how to best support equitable access for all, complementary research approaches, namely qualitative inquiry and community-based participatory research, are necessary [6, 11, 36].
Next, using our analyses in this paper as an example, we demonstrate one way to expand the utility of innovative data visualization techniques, such as the equiplot. In Fig. 4, obvious discrepancies exist in the proportions of cohort participants from different geographic regions in Manitoba falling within each cascade step. Of particular interest to the Manitoba HIV Program may be the relatively low proportions of individuals living in western Manitoba categorized as in care and the substantial leakage at the virologically suppressed step among participants living in southern Manitoba. Indeed, previous research has also identified substantial geographic heterogeneity in engagement in HIV care [31, 37], some of which may be attributable to limited access to services due to physical distance , or other individual-, community-, and structural-level barriers [32, 37, 39]. Although our disaggregated analyses have provided a useful starting point for understanding geographic heterogeneity in HIV care in Manitoba, further mixed methods explorations will be necessary to delve into understanding the complex circumstances that shape inequities along the cascade before meaningful recommendations can be made to inform local programming or policy. A next step to understand geographic inequalities will require further disaggregating data (e.g. by sex, age, socioeconomic status) to uncover whether specific groups within geographic regions are further vulnerable to suboptimal engagement. Once a reasonable level of granularity is achieved in identifying “key groups” who may require additional support to engage in HIV care, program adjustments and policy development should then be based upon further-contextualized understandings of barriers to engagement in care through meaningful community involvement in program and policy decisions [11, 36]. Policy and programmatic decisions aimed at reducing health inequities must incorporate nuanced conceptualizations of how the various factors that influence access to and engagement with necessary and appropriate health services interact and overlap  to create specific conditions that prevent individuals from progressing through the HIV care cascade and other care continua . If these complexities are not considered, and instead the linear logic inherent to the cascade  is privileged, policies intended to reduce gaps in equity will continue to miss the mark.
This study has a few limitations that must be noted. First, a number of limitations inherent to the design of our clinical cohort have been described in detail elsewhere [14,15,16,17]. Opportunities to participate in the cohort are introduced to individuals in the context of their clinic appointments with the Manitoba HIV Program; participation is optional and does not impact the way that HIV care and other services are received. Still, we have to assume that selection bias may be influencing our analyses, and actual engagement in HIV care among the clinic population may be lower than we are able to assess from the cohort. For the same reasons, we cannot presume that our findings are generalizable to the broader population of people living with HIV in Manitoba, although previous work suggests that these data are reasonably representative of larger population in HIV care in Manitoba . Second, using the LHIV-Manitoba cohort as a starting point for the first step of the cascade means that we cannot ascertain information about the proportion of people living with undiagnosed HIV in Manitoba and thus limits our ability to generate provincial estimates for all 90–90-90 targets. Finally, available data were limited such that we were unable to analyse the Manitoban HIV care cascade by income, level of education, or other socioeconomic status (SES) indicators. This will be an important addition to this work, which we will undertake as we move forward with more detailed analyses of our cohort data.
Our findings highlight a need for further investigation into the complex and dynamic circumstances that shape the lives of people living with HIV in Manitoba and, ultimately, influence the ability of certain groups to engage in their HIV care. While our cascade equity analyses provide a useful starting point to work toward achieving health equity and leaving no one behind for people living with HIV in Manitoba, eliciting meaningful policy and programming change will require deeper, more comprehensive work to understand barriers and facilitators to engagement in care.
Availability of data and materials
Researchers interested in accessing data related to the LHIV-Manitoba cohort should be directed to Dr. Marissa Becker (firstname.lastname@example.org). All access requests for individual-level data must be accompanied by proposals for the research projects and will be subject to approvals by Health Research Ethics Board at the University of Manitoba, as well as the researchers’ home institution. Aggregate and/or de-identified data may be shared with fewer restrictions pending review by the LHIV-Manitoba study team.
95% confidence interval
Adjusted odds ratio
Canadian Institutes of Health Research
Human immunodeficiency virus
International Classifications of Diseases-9/10
Injection drug use
The Advancing Primary Healthcare for Persons Living with HIV in Canada Study
Millennium Development Goals
Manitoba Health, Seniors and Active Living
Men having condomless anal sex with other men
Public Health Agency of Canada
Sustainable Development Goals
University of Manitoba Health Research Ethics Board
Haddad N, Robert A, Weeks A, Popovic N, Siu W, Archibald C. HIV in Canada - surveillance report, 2018. Can Comm Dis Rep. 2019;45(12):304–12.
Manitoba HIV. Program: 2018 Manitoba HIV Program Update. In: Winnipeg MB, editor. Nine Circles Community Health Centre; 2019.
Government of Manitoba. 2018 Annual Statistical Update: HIV in Manitoba. In: Winnipeg MB, editor. Manitoba Health, Seniors and Active living; 2019.
Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.
Haber N, Pillay D, Porter K, Barnighausen T. Constructing the cascade of HIV care: methods for measurement. Curr Opin HIV AIDS. 2016;11(1):102–8.
Seckinelgin H. People don’t live on the care cascade: the life of the HIV care cascade as an international AIDS policy and its implications. Glob Public Health. 2020;15(3):321–33.
UNAIDS. 90–90-90: an ambitious treatment target to help end the AIDS epidemic. Geneva: United Nations; 2014.
United Nations. Transforming our world: the 2030 agenda for sustainable development. New York, NY: United Nations; 2015.
United Nations sustainable development group: Leaving no one behind: a UNSDG operational guide for UN country teams in., vol. interim draft - 18 March 2019: United Nations; 2019.
Marmot M, Bell R. The sustainable development goals and health equity. Epidemiology. 2018;29(1):5–7.
Zamora G, Koller TS, Thomas R, Manandhar M, Lustigova E, Diop A, Magar V. Tools and approaches to operationalize the commitment to equity, gender and human rights: towards leaving no one behind in the Sustainable Development Goals. Glob Health Action. 2018;11(sup1):1463657.
United Nations General Assembly. In: Nations U, vol. A/RES/71/313, editor. Global indicator framework for the Sustainable Development Goals and targets of the 2030 Agenda for Sustainable Development: United Nations; 2017.
Braveman P. Health disparities and health equity: concepts and measurement. Annu Rev Public Health. 2006;27:167–94.
Shoemaker ES, Becker ML, Liddy CE, McClarty LM, Asghari S, Hurd J, Rourke SB, Shaw SY, Bibeau C, Rosenes R, et al. Creating clinical cohorts: challenges encountered in two Canadian provinces. Healthc Policy. 2019;15(1):10–8.
McClarty LM, Cheuk E, Ireland L, Kendall C, Bibeau C, Loeppky C, Kasper K, Keynan Y, Blanchard J, Becker M. Cohort profile: the LHIV-Manitoba clinical cohort of people living with HIV in Manitoba, Canada. BMJ Open. 2020;10(5):e034259.
McClarty LM. A critical exploration into Manitoba’s HIV care cascade. Dissertation on the Internet. Winnipeg: University of Manitoba; 2020.
McClarty LM, Kasper K, Ireland L, Loeppky C, Blanchard JF, Becker ML. The HIV care cascade in Manitoba, Canada: Methods, measures, and estimates to meet local needs. J Clin Epidemiol. 2020;132:26–33.
Douglas MD, Josiah Willock R, Respress E, Rollins L, Tabor D, Heiman HJ, Hopkins J, Dawes DE, Holden KB. Applying a health equity Lens to evaluate and inform policy. Ethn Dis. 2019;29(Suppl 2):329–42.
Minnesota Department of Health. HEDA: Conducting a Health Equity Data Analyses - A guide for local health departments in Minnesota. In., vol. 2. St. Paul, MN: Minnesota Department of Health; 2018.
Government of Manitoba. Population Report June 1, 2018. Winnipeg, MB: Manitoba Health, Healthy Living and Seniors; 2018.
Yoong D, Bayoumi AM, Robinson L, Rachlis B, Antoniou T. Public prescription drug plan coverage for antiretrovirals and the potential cost to people living with HIV in Canada: a descriptive study. CMAJ Open. 2018;6(4):E551–60.
Ontario HIV Epidemiology and Surveillance Initiative. HIV care cascade in Ontario by sex, age and health region: Linkage to care, in care, on antiretroviral treatment and virally suppressed, 2015. Toronto, ON: Ontario HIV Epidemiology and Surveillance Initiative; 2018.
Nosyk B, Montaner JS, Colley G, Lima VD, Chan K, Heath K, Yip B, Samji H, Gilbert M, Barrios R, et al. The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study. Lancet Infect Dis. 2014;14(1):40–9.
Public Health Agency of Canada. HIV and AIDS in Canada: Surveillance Report to December 31, 2013. Ottawa: Public Health Agency of Canada; 2014.
Manitoba Centre for Health Policy. Concept: Regional Health Authority (RHA) Districts and Zones in Manitoba. Winnipeg: University of Manitoba; 2013. Available from: http://mchp-appserv.cpe.umanitoba.ca/viewConcept.php?printer=Y&conceptID=1219. Accessed 27 Mar 2020.
Klein A. HIV/AIDS and immigration: final report. Toronto, ON: Canadian HIV/AIDS Legal Network; 2001.
International Center for Equity in Health. Equiplot Pelotas, Brazil. Brazil: Universidade Federal de Pelotas. Available from: https://www.equidade.org/equiplot. Accessed 20 Jan 2020.
Kerkerian G, Kestler M, Carter A, Wang L, Kronfli N, Sereda P, Roth E, Milloy MJ, Pick N, Money D, et al. Attrition across the HIV cascade of care among a diverse cohort of women living with HIV in Canada. J Acquir Immune Defic Syndr. 2018.
Horberg MA, Hurley LB, Klein DB, Towner WJ, Kadlecik P, Antoniskis D, Mogyoros M, Brachman PS, Remmers CL, Gambatese RC, et al. The HIV care Cascade measured over time and by age, sex, and race in a large National Integrated Care System. AIDS Patient Care STDs. 2015;29(11):582–90.
Lurie MN, Kirwa K, Callaway J, Cornell M, Boulle A, Bengtson AM, Smith M, Leon N, Colvin C. Quantifying the HIV treatment cascade in a south African health sub-district by gender: retrospective cohort study. Tropical Med Int Health. 2020;25(2):186–92.
Eberhart MG, Yehia BR, Hillier A, Voytek CD, Blank MB, Frank I, Metzger DS, Brady KA. Behind the cascade: analyzing spatial patterns along the HIV care continuum. J Acquir Immune Defic Syndr. 2013;64(Suppl 1):S42–51.
Eberhart MG, Yehia BR, Hillier A, Voytek CD, Fiore DJ, Blank M, Frank I, Metzger DS, Brady KA. Individual and community factors associated with geographic clusters of poor HIV care retention and poor viral suppression. J Acquir Immune Defic Syndr. 2015;69(Suppl 1):S37–43.
UNAIDS. Understanding fast-track: accelerating action to end the AIDS epidemic by 2030. Geneva: UNAIDS; 2015.
World Health Organization. Consolidated guidelines on person-centred HIV patient monitoring and case surveillance. Geneva: World Health Organization; 2017. p. 224.
Marmot M, Allen JJ. Social determinants of health equity. Am J Public Health. 2014;104(Suppl 4):S517–9.
Macdonald V, Verster A, Seale A, Baggaley R, Ball A. Universal health coverage and key populations. Curr Opin HIV AIDS. 2019;14(5):433–8.
Schafer KR, Albrecht H, Dillingham R, Hogg RS, Jaworsky D, Kasper K, Loutfy M, MacKenzie LJ, McManus KA, Oursler KA, et al. The continuum of HIV Care in Rural Communities in the United States and Canada: what is known and future research directions. J Acquir Immune Defic Syndr. 2017;75(1):35–44.
Masiano SP, Martin EG, Bono RS, Dahman B, Sabik LM, Belgrave FZ, Adimora AA, Kimmel AD. Suboptimal geographic accessibility to comprehensive HIV care in the US: regional and urban-rural differences. J Int AIDS Soc. 2019;22(5):e25286.
Levesque JF, Harris MF, Russell G. Patient-centred access to health care: conceptualising access at the interface of health systems and populations. Int J Equity Health. 2013;12:18.
This work was conducted on Treaty 1 and Treaty 2 territories, the original lands of the Anishinaabeg, Cree, Oji-Cree, Dakota, and Dene peoples and the homeland of the Métis Nation. We thank our colleagues the Health Information Research Governance Committee of Nanaandawewigamig, the First Nations Health and Social Secretariat of Manitoba for their support. We also wish to acknowledge our collaborators at Manitoba Health, Seniors and Active Living’s Information Management & Analytics team. The results and conclusions are those of the authors and no official endorsement by MHSAL or other data providers is intended or should be inferred. Thank you, also, to providers and staff at the Manitoba HIV Program and the LHIV Study team, in particular Dr. Claire Kendall. Finally, and most importantly, we gratefully acknowledge the time and contributions of our cohort participants, without whom this work could not exist.
The LHIV Study is funded by the Canadian Institutes of Health Research (CIHR, funding reference no. TT5–128270). LMM received funding from the CIHR Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award, the CIHR Michael Smith Foreign Study Supplement, the University of Manitoba, and the Canadian Association for HIV Research to support this work. The funders played no role in designing this study; collecting, analysing, interpretating data; nor in writing this manuscript.
Ethics approval and consent to participate
All participants included in the LHIV-Manitoba clinical cohort provided written, informed consent to have their clinical and administrative health data collected and analyzed. This work, including informed consent procedures, received approval from the University of Manitoba’s Health Research Ethics Board (UM-HREB, HS21678). The larger cohort study in which this work is embedded received approvals from UM-HREB (HS15817), the local hospital’s Research Impact Committee, the Health Information Privacy Committee of MHSAL, and the Nine Circles Community Health Centre Research Committee. The cohort study also received support from the Health Information Research Governance Committee of Nanaandawewigamig, the First Nations Health and Social Secretariat of Manitoba.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
McClarty, L.M., Blanchard, J.F. & Becker, M.L. Leaving no one behind? An equity analysis of the HIV care cascade among a cohort of people living with HIV in Manitoba, Canada. BMC Public Health 21, 281 (2021). https://doi.org/10.1186/s12889-021-10225-w
- Cohort studies
- Retention in care
- Patient care